Januvia sitagliptin: Additional Phase III data

Additional data from a 24-week, double-blind, placebo-controlled Phase III trial in 1,091 patients showed that

Read the full 153 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE